Sweden · Delayed Price · Currency is SEK BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of SEK 10.94 billion. The enterprise value is 10.21 billion.
| Market Cap | 10.94B |
| Enterprise Value | 10.21B |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
BioGaia AB has 101.16 million shares outstanding. The number of shares has increased by 0.08% in one year.
| Current Share Class | 98.50M |
| Shares Outstanding | 101.16M |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.78% |
| Owned by Institutions (%) | 40.81% |
| Float | 70.12M |
Valuation Ratios
The trailing PE ratio is 34.65 and the forward PE ratio is 27.72.
| PE Ratio | 34.65 |
| Forward PE | 27.72 |
| PS Ratio | 7.48 |
| PB Ratio | 8.98 |
| P/TBV Ratio | 10.25 |
| P/FCF Ratio | 33.92 |
| P/OCF Ratio | 33.63 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 23.12, with an EV/FCF ratio of 31.66.
| EV / Earnings | 32.31 |
| EV / Sales | 6.98 |
| EV / EBITDA | 23.12 |
| EV / EBIT | 21.86 |
| EV / FCF | 31.66 |
Financial Position
The company has a current ratio of 6.27
| Current Ratio | 6.27 |
| Quick Ratio | 4.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 166.59 |
Financial Efficiency
Return on equity (ROE) is 22.26% and return on invested capital (ROIC) is 71.77%.
| Return on Equity (ROE) | 22.26% |
| Return on Assets (ROA) | 17.21% |
| Return on Invested Capital (ROIC) | 71.77% |
| Return on Capital Employed (ROCE) | 35.60% |
| Revenue Per Employee | 6.14M |
| Profits Per Employee | 1.33M |
| Employee Count | 225 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioGaia AB has paid 86.21 million in taxes.
| Income Tax | 86.21M |
| Effective Tax Rate | 21.44% |
Stock Price Statistics
The stock price has decreased by -5.09% in the last 52 weeks. The beta is 0.43, so BioGaia AB's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -5.09% |
| 50-Day Moving Average | 102.73 |
| 200-Day Moving Average | 102.83 |
| Relative Strength Index (RSI) | 55.22 |
| Average Volume (20 Days) | 211,578 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of SEK 1.46 billion and earned 315.92 million in profits. Earnings per share was 3.12.
| Revenue | 1.46B |
| Gross Profit | 1.06B |
| Operating Income | 466.95M |
| Pretax Income | 402.13M |
| Net Income | 315.92M |
| EBITDA | 432.71M |
| EBIT | 466.95M |
| Earnings Per Share (EPS) | 3.12 |
Balance Sheet
The company has 728.10 million in cash and n/a in debt, with a net cash position of 728.10 million or 7.20 per share.
| Cash & Cash Equivalents | 728.10M |
| Total Debt | n/a |
| Net Cash | 728.10M |
| Net Cash Per Share | 7.20 |
| Equity (Book Value) | 1.22B |
| Book Value Per Share | 12.04 |
| Working Capital | 924.08M |
Cash Flow
In the last 12 months, operating cash flow was 325.18 million and capital expenditures -2.76 million, giving a free cash flow of 322.42 million.
| Operating Cash Flow | 325.18M |
| Capital Expenditures | -2.76M |
| Free Cash Flow | 322.42M |
| FCF Per Share | 3.19 |
Margins
Gross margin is 72.71%, with operating and profit margins of 31.93% and 21.60%.
| Gross Margin | 72.71% |
| Operating Margin | 31.93% |
| Pretax Margin | 27.50% |
| Profit Margin | 21.60% |
| EBITDA Margin | 29.59% |
| EBIT Margin | 31.93% |
| FCF Margin | 22.05% |
Dividends & Yields
This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 6.38%.
| Dividend Per Share | 6.90 |
| Dividend Yield | 6.38% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 61.13% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 6.35% |
| Earnings Yield | 2.89% |
| FCF Yield | 2.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |